New Full-Body Scan Detects Up To 11 Cancers In Men and 13 In Women

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

Ezra, the technology-driven healthcare company creating a new standard for early cancer detection launched its full-body MRI scanning program. Ezra provides its members with a direct-to-consumer service that enables them to get screened for cancer using an MRI scan that’s fast, accurate, and affordable. Ezra’s new full-body protocol can detect up to 11 cancers in men and 13 in women.

“We should all check our bodies for cancer as part of our routine health regimen. To make that possible, we’re aiming to combine a  better patient experience with the most advanced medical imaging technology and the latest developments in artificial intelligence,” said Emi Gal, CEO & co-founder of Ezra. “Our goal is to improve the speed, accuracy and affordability of cancer screening, and I’m thrilled to be announcing our full-body MRI-based cancer screening program.”

cancersIn an effort to make MRI-based cancer screening affordable to as many people as possible, Ezra offers multiple plans: The Ezra Full-Body Scan is available for $1,950, and single-region scans (such as pelvic or abdominal) are available for as little as $675. Members can also pay using a no-interest payment plan in 12 monthly installments.

The American Cancer Society estimates that there will be over 1.7 million new cases of cancer diagnosed in the United States this year alone — over 600,000 of which will be lethal.1 Almost 50% of cancer patients are detected late2, and only 2 out of 10 late-stage cancer patients survive longer than 5 years.3 Ezra’s mission is to help all these men and women detect cancer early, by creating fast, accurate, affordable and non-invasive cancer screening solutions.

In January 2019, Ezra launched its MRI-based prostate cancer screening program. The program’s goal is to leverage new technologies to catch prostate cancer as early as possible and help men avoid unnecessary prostate biopsies. Since the launch, almost 1,000 individuals have signed up, hundreds of men have been scanned, and Ezra has successfully helped members detect prostate cancer and avoid unnecessary prostate biopsies.

“We are developing innovative AI technologies that assist radiologists in detecting cancer earlier, faster, and more accurately than ever before. I cannot think of a better use of AI than to help people live longer and healthier lives,” says CTO and co-founder Diego Cantor, PhD.

In the four months since launch, Ezra has also assembled a stellar board of medical advisors, including Columbia’s Dr. Azra Raza, Dr. Siddhartha Mukherjee, and Dr. Joseph Alukal, Dr. Oguz Akin from Memorial Sloan Kettering Cancer Center, as well as RadNet’s Dr. Lawrence N. Tanenbaum, Dr. John Melnick and Dr. Charles Fiske. The company has also expanded to eight new imaging facilities across New York’s five boroughs and New Jersey. Ezra plans to expand to additional U.S. cities by the end of the year, providing early cancer detection to men and women across the country.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.